These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

125 related articles for article (PubMed ID: 38957407)

  • 1. Corrigendum: HSA-nanobinders crafted from bioresponsive prodrugs for combined cancer chemoimmunotherapy-an
    Tubertini M; Menilli L; Milani C; Martini C; Navacchia ML; Nugnes M; Bartolini M; Naldi M; Tedesco D; Martella E; Guerrini A; Ferroni C; Moret F; Varchi G
    Front Chem; 2024; 12():1443822. PubMed ID: 38957407
    [TBL] [Abstract][Full Text] [Related]  

  • 2. HSA-nanobinders crafted from bioresponsive prodrugs for combined cancer chemoimmunotherapy-an
    Tubertini M; Menilli L; Milani C; Martini C; Navacchia ML; Nugnes M; Bartolini M; Naldi M; Tedesco D; Martella E; Guerrini A; Ferroni C; Moret F; Varchi G
    Front Chem; 2024 Mar; 12():1378233. PubMed ID: 38591056
    [TBL] [Abstract][Full Text] [Related]  

  • 3. HSA-Binding Prodrugs-Based Nanoparticles Endowed with Chemo and Photo-Toxicity against Breast Cancer.
    Rapozzi V; Moret F; Menilli L; Guerrini A; Tedesco D; Naldi M; Bartolini M; Gani M; Zorzet S; Columbaro M; Milani C; Martini C; Ferroni C; Varchi G
    Cancers (Basel); 2022 Feb; 14(4):. PubMed ID: 35205627
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Human Serum Albumin-Oxaliplatin (Pt(IV)) prodrug nanoparticles with dual reduction sensitivity as effective nanomedicine for triple-negative breast cancer.
    Paul M; Ghosh B; Biswas S
    Int J Biol Macromol; 2024 Jan; 256(Pt 1):128281. PubMed ID: 37992920
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Reduction-Responsive Docetaxel Prodrug Encapsulated within Human Serum Albumin Nanoparticles for Cancer Therapy.
    Zhang Y; Zhang H; Wang J; Liu C; Xing H; Jiang Y; Li X
    Mol Pharm; 2023 May; 20(5):2513-2526. PubMed ID: 37071030
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Developing an anticancer copper(II) pro-drug based on the nature of cancer cell and human serum albumin carrier IIA subdomain: mouse model of breast cancer.
    Gou Y; Zhang Y; Qi J; Chen S; Zhou Z; Wu X; Liang H; Yang F
    Oncotarget; 2016 Oct; 7(41):67004-67019. PubMed ID: 27564255
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Design of an Anticancer Copper(II) Prodrug Based on the Lys199 Residue of the Active Targeting Human Serum Albumin Nanoparticle Carrier.
    Gou Y; Zhang Y; Zhang Z; Wang J; Zhou Z; Liang H; Yang F
    Mol Pharm; 2017 Jun; 14(6):1861-1873. PubMed ID: 28471669
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The potential use of lapatinib-loaded human serum albumin nanoparticles in the treatment of triple-negative breast cancer.
    Wan X; Zheng X; Pang X; Zhang Z; Jing T; Xu W; Zhang Q
    Int J Pharm; 2015 Apr; 484(1-2):16-28. PubMed ID: 25700543
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Biomimetic Human Serum Albumin Nanoparticle for Efficiently Targeting Therapy to Metastatic Breast Cancers.
    Liu L; Bi Y; Zhou M; Chen X; He X; Zhang Y; Sun T; Ruan C; Chen Q; Wang H; Jiang C
    ACS Appl Mater Interfaces; 2017 Mar; 9(8):7424-7435. PubMed ID: 28150932
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Corrigendum: Confinement of Suspension-Cultured Cells in Polyethylene Glycol/Polyethylene Oxide-Albumin Aqueous Two-Phase Systems.
    Teixeira AG; Kleinman A; Agarwal R; Tam NW; Wang J; Frampton JP
    Front Chem; 2019; 7():670. PubMed ID: 31632955
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Bioresponsive albumin-conjugated paclitaxel prodrugs for cancer therapy.
    Yang J; Lv Q; Wei W; Yang Z; Dong J; Zhang R; Kan Q; He Z; Xu Y
    Drug Deliv; 2018 Nov; 25(1):807-814. PubMed ID: 29553858
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Olaparib@human serum albumin nanoparticles as sustained drug-releasing tumour-targeting nanomedicine to inhibit growth and metastasis in the mouse model of triple-negative breast cancer.
    Vysyaraju NR; Paul M; Ch S; Ghosh B; Biswas S
    J Drug Target; 2022 Dec; 30(10):1088-1105. PubMed ID: 35723068
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Corrigendum:
    Zhao R; Zhao C; Wan Y; Majid M; Abbas SQ; Wang Y
    Front Chem; 2024; 12():1373205. PubMed ID: 38370092
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Human serum albumin-based doxorubicin prodrug nanoparticles with tumor pH-responsive aggregation-enhanced retention and reduced cardiotoxicity.
    Zhang B; Wan S; Peng X; Zhao M; Li S; Pu Y; He B
    J Mater Chem B; 2020 May; 8(17):3939-3948. PubMed ID: 32236239
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Evans Blue Derivative-Functionalized Gold Nanorods for Photothermal Therapy-Enhanced Tumor Chemotherapy.
    Wang X; Gao S; Qin Z; Tian R; Wang G; Zhang X; Zhu L; Chen X
    ACS Appl Mater Interfaces; 2018 May; 10(17):15140-15149. PubMed ID: 29648446
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Lapatinib-loaded human serum albumin nanoparticles for the prevention and treatment of triple-negative breast cancer metastasis to the brain.
    Wan X; Zheng X; Pang X; Pang Z; Zhao J; Zhang Z; Jiang T; Xu W; Zhang Q; Jiang X
    Oncotarget; 2016 Jun; 7(23):34038-51. PubMed ID: 27086917
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Corrigendum: Influence of carrier effect on Pd/Al
    Peng S; Ma Z; Ma J; Wang H; Chen J; Wei H; Li Y; Ao Z; Wang B
    Front Chem; 2022; 10():1085035. PubMed ID: 36451928
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Nanoparticles for Chemoimmunotherapy Against Triple-Negative Breast Cancer.
    Liu S; Li J; Gu L; Wu K; Xing H
    Int J Nanomedicine; 2022; 17():5209-5227. PubMed ID: 36388877
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Corrigendum: Detection methods of nanoparticles synthesized by gas-phase method: a review.
    Zhang X; Zhao X; Li H; Hao X; Xu J; Tian J; Wang Y
    Front Chem; 2023; 11():1351829. PubMed ID: 38156019
    [TBL] [Abstract][Full Text] [Related]  

  • 20. A Versatile Platform to Generate Prodrugs with Rapid and Precise Albumin Hitchhiking and High Cargo Loading for Tumor-Targeted Chemotherapy.
    Li J; Xing H; Chen J; Lu H; Tao Z; Tao Y; Sun Y; Su T; Li X; Chang H; Chen S; Chen Z; Yang H; Cheng J; Zhu H; Lu X
    Small; 2024 Mar; 20(13):e2304253. PubMed ID: 37963821
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.